UP

Cancer immunotherapy drug 'less toxic and prolongs life'

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto

An immunotherapy drug that could save some cancer patients from the ordeal of extreme chemotherapy may also help them live longer, researchers say.

Axar.az reports citing BBC.

In a trial, pembrolizumab kept head and neck cancers at bay for an average of two years - five times longer than under chemotherapy.

The patients also suffered far fewer side-effects.

Cases of head and neck cancers are rising in the UK and most are diagnosed late, when they are hard to treat.

Date
2019.11.23 / 21:56
Author
Axar.az
Comments
See also

WHO: Gaza's hospital not functional after Israel raids

This country is starting mass vaccination against fever

Urgent call from WHO on measles

The creator of the Sputnik V vaccine has died

Thousands of people died from coronavirus on the holiday

Uzbekistan develops edible COVID vaccine made from tomato

Infection has increased, use the mask! - Warning

Diseases could kill more than bombings in Gaza - WHO

A vaccine against cancer will be developed

World first: Human eye transplanted

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla